These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5510366)

  • 1. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G; Kraupp O
    Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with coronary-active drugs.
    Haas H
    Brux Med; 1970 Sep; 50(9):665-8. PubMed ID: 5510369
    [No Abstract]   [Full Text] [Related]  

  • 4. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epontol and coronary circulation].
    Garcia Betancourt L
    Anaesthesist; 1970 Jan; 19(1):48-51. PubMed ID: 5440158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
    Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
    Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic bases of antiangina properties of amiodarone].
    Charlier R
    Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the necessity to resume and enlarge pharmacologic and clinical studies of a molecule during the advancement of its therapeutic utilization: pharmacology of trimetazidine].
    Vigne J
    Brux Med; 1970 Sep; 50(9):601-8. PubMed ID: 5510360
    [No Abstract]   [Full Text] [Related]  

  • 10. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O; Grossmann W; Stühlinger W; Raberger G
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of nitranol, nitropenton and nitrosorbid on the rate of the coronary blood flow and on the oxygen consumption of the myocardium].
    Buianov VV
    Farmakol Toksikol; 1967; 30(1):30-4. PubMed ID: 5594355
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the mechanism of action of coronary dilators].
    Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selective influencing of the myocardial blood supply in dogs using drugs].
    Hapke HJ
    Dtsch Tierarztl Wochenschr (1946); 1969 Oct; 76(19):518-21. PubMed ID: 5355903
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of a new drug (hexobendine) on cerebral hemodynamics and oxygen consumption.
    Meyer JS; Kondo A; Szewczykowski J; Nomura F; Teraura T
    J Neurol Sci; 1970 Aug; 11(2):137-45. PubMed ID: 4989597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses].
    Kraupp O; Wolner E; Adler-Kastner L; Chirikdjian JJ; Ploszczanski B; Tuisl E
    Arzneimittelforschung; 1966 Jun; 16(6):692-7. PubMed ID: 6014577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.